Quest Diagnostics Launches Convenient Self-Collection for GTI Testing
Quest Diagnostics Innovations in Genital Tract Infection Testing
Quest Diagnostics (NYSE: DGX) is revolutionizing the way patients access testing for genital tract infections (GTIs) with a groundbreaking self-collection service. This initiative aims to enhance discretion and convenience for individuals seeking testing and treatment for conditions like vaginitis, chlamydia, gonorrhea, trichomoniasis, and Mycoplasma genitalium.
Empowering Patients with Self-Collection Options
With this first-of-its-kind service, patients can collect swab specimens themselves at any of Quest's 2,000 patient service centers, provided they have a physician's order. This self-collection option is available at no additional cost, allowing patients to engage more actively in their healthcare.
Improving Accessibility to Health Services
“At Quest, our goal is to empower patients by offering them choices that enhance their healthcare experience,” shared Kathleen Valentine, Vice President and General Manager of Women's and Reproductive Health Services at Quest Diagnostics. By enabling self-collection, Quest is making significant strides toward improving access to vital sexual health testing.
The Self-Collection Process Explained
Utilizing the FDA-cleared Aptima® Multi-test swab, patients can self-collect vaginal specimens in a private setting at Quest's centers. The process is straightforward and guided by clear instructions. However, some individuals may find self-collection challenging and may need to consult a healthcare professional for assistance. Once collected, the specimens are forwarded to the laboratory for testing, delivering results electronically to both the patient and their healthcare provider.
The Importance of Timely Testing
Untreated GTIs can lead to severe long-term health issues, such as pelvic inflammatory disease, chronic pain, infertility, and complications during pregnancy. Recognizing these risks, Dr. Damian P. Alagia, Senior Medical Director at Quest, emphasizes that specimen self-collection offers women a comfortable alternative that maintains testing accuracy.
Overview of Common Infections Tested
The new self-collection method facilitates laboratory testing for various infections, notably bacterial vaginosis (BV), vulvovaginal candidiasis (commonly known as yeast infection), and trichomoniasis. Given that one in three women experiences vaginitis at some point in their lives, this service is a significant advancement in women's health.
Enhancing Patient Care and Experience
This innovative service allows patients to take charge of their health in a discreet manner, while also alleviating some of the burdens from healthcare providers who may be pressed for time. A recent survey found that over half of respondents prioritize convenience and accessibility when making healthcare decisions, underscoring the relevance of Quest's offering.
Choices Beyond the Patient Service Centers
In addition to utilizing physician orders, patients can also opt for self-collection through Quest's consumer-initiated testing platform. This platform provides a simple way to order labs for testing various GTIs and allows for follow-up consultations with licensed physicians through the PWNHealth network. This ensures that patients can receive comprehensive care based on their testing outcomes.
Quest Diagnostics Commitment to Health
Quest Diagnostics is dedicated to advancing health for individuals and communities. As a leading diagnostic provider, the company plays a key role in health management by delivering insights derived from extensive clinical data. Its diagnostic capabilities enable better identification, treatment, and overall management of health conditions across the United States, serving a significant portion of the adult population and healthcare practitioners.
Frequently Asked Questions
What types of infections can be tested with this new service?
The self-collection method is applicable for various infections, including bacterial vaginosis, candidiasis, trichomoniasis, chlamydia, and gonorrhea.
Do patients need a physician's order for self-collection?
Yes, a physician's order is required to utilize the self-collection option at Quest's patient service centers.
Is there an additional cost associated with self-collection?
No, there is no extra charge for patients choosing the self-collection option.
How does the self-collection process work?
Patients will receive step-by-step instructions for collecting samples in a private room, following which samples are sent to Quest for testing.
Can patients discuss results with a physician?
Yes, patients can consult with a licensed physician to discuss test results and receive potential treatment options.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- Kiro Race Co: A Fresh Start in the ABB FIA Formula E Championship
- Walgreens Boots Alliance Sees Growth Amid Cost-Cutting Efforts
- Investigation Launched for Investors of Sprinklr, Inc. Claims
- Legal Support for Shareholders: Investigating Key Transactions
- WSFS Bank Launches Food Drive to Combat Food Insecurity
- LiveOnNY Launches Innovative Simulation Center for Organ Donation
- Investigation Launched for Investors in Ardelyx Inc. Claims
- Walmart's Stock Activity Explained: Insights for Investors
- Kforce Stock Upgrade: Sidoti's Optimistic Buy Rating
- IFS Cloud Launches Module to Address ESG Compliance Challenges
Recent Articles
- Abcourt Advances Exploration with Second Stripping Phase Success
- Daily Pecan Consumption: A Heart-Healthy Choice Revealed
- Acadian Plant Health and BASF Join Forces for Sustainable Farming
- JBT Bancorp Reports Impressive Earnings Growth in Q3 2024
- Collaboration for Climate-Resilient Agriculture: Acadian & BASF
- Chipotle Invests in Innovative Food Technology and Concepts
- Walker River's Lapon Gold Project: Latest Assay Results Unveiled
- Supporting Survivors: Insights from Domestic Violence Impact Report
- BioVie Secures Patent Approval for Innovative Terlipressin Formula
- Omega Therapeutics Set to Showcase Groundbreaking Research at Conferences
- Sticker Mule Enhances Operations with Rumble Cloud AI Services
- Prime Medicine Previews Innovations in Genetic Therapy Research
- InterDigital Sets Date for Upcoming Financial Results Release
- Talkspace to Announce Q3 2024 Results with Conference Call
- UBS Reports on Platinum's Price Stability Amid Supply Challenges
- Altimmune to Showcase Pemvidutide Data at The Liver Meeting 2024
- Galectin Therapeutics Showcases Major Advances in Liver Health Research
- MicroStrategy vs Marathon: The Battle for Bitcoin Dominance
- Mark Cuban Highlights Kamala Harris's Growing Crypto Acumen
- Landstar Prepares to Announce Q3 Financial Performance Soon
- IPG Photonics Set to Share Financial Insights for Q3 2024
- Walgreens Announces Significant Store Closures in Restructuring
- Annovis Bio Charts New Course Following FDA Phase 3 Clearance
- T. Rowe Price and Pacific Life Team Up for Retirement Security
- Goldman Sachs Reports Record Earnings with 45% Profit Jump
- Gig Work: Flexibility and Income Drive Workforce Trends
- Monopar Therapeutics Advances Cancer Treatment with Patent Filing
- Absci Corporation's Upcoming Financial Update: Key Insights
- Delimex Introduces Crispy Quesadillas for Home Enjoyment
- Ardelyx Showcases Key Findings for XPHOZAH in Kidney Disease
- Mandalay Resources Welcomes John Jentz to Board of Directors
- Xtreme One Entertainment Opens New Doors for Investors with Stock Offering
- Nevada King Gold Corp. Names John Sclodnick New President
- Logicalis Unveils Sustainable IT Strategy for Carbon Neutrality
- Unlocking Service Efficiency: QLESS Introduces Service Intelligence
- Landstar to Share Q3 Results and Conference Call Details Soon
- Innovative Approaches in Obesity Treatment Discussed by ZyVersa CEO
- GoGold's Impressive Quarterly Production Exceeds Expectations
- LONGi Launches Innovative Hi-MO X10 Modules at Shanghai Event
- BriaCell Advances Pivotal Study for Metastatic Breast Cancer Therapy
- AVS Initiates Pivotal Study for Intravascular Treatment
- Nova Leap Health Corp. Expands Its Presence in Florida Market
- Mexico's Path to Growth: Embracing Nearshoring Opportunities
- Breast Cancer Awareness Month: Biotechnology Innovations for Women
- Dr. Danninger Joins Circus Group Board to Revolutionize Robotics
- Epitomee Medical Unveils Innovative Oral Delivery at PODD 2024
- Alpha Metallurgical Delivers Positive Preliminary Q3 Results
- Discover Epitomee Medical's Innovative Oral Delivery Solutions
- DermCare Management Strengthens California Expansion with New Partner
- Jazz Pharmaceuticals Advances Lung Cancer Treatment with Zepzelca